Evaluation of immune cell markers in tumor tissue treated with radioimmunotherapy in an immunocompetent rat colon carcinoma model.

Erika Elgström; Sophie Eriksson; Otto Ljungberg; Pär-Ola Bendahl; Tomas G Ohlsson; Rune Nilsson; Jan Tennvall

doi:10.1186/s13550-015-0126-y

Evaluation of immune cell markers in tumor tissue treated with radioimmunotherapy in an immunocompetent rat colon carcinoma model.

Erika Elgström, Sophie Eriksson, Otto Ljungberg, Pär-Ola Bendahl, Tomas G Ohlsson, Rune Nilsson, Jan Tennvall

Research output: Contribution to journal › Article › peer-review

Abstract

Immune cells within the tumor can act either to promote growth or rejection of tumor cells. The aim of the present study was to evaluate immune cell markers (number and localization) within the tumor before and during rejection due to radioimmunotherapy, to determine whether there is a change in markers related to rejection and/or tolerance of the tumor cells.

Original language	English
Article number	47
Journal	EJNMMI Research
Volume	5
DOIs	https://doi.org/10.1186/s13550-015-0126-y
Publication status	Published - 2015

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s13550-015-0126-y

http://www.ncbi.nlm.nih.gov/pubmed/26374556?dopt=Abstract

1 Doctoral Thesis (compilation)

Radioimmunotherapy in an Immunocompetent Tumor Model utilizing a 177Lu-mAb
Elgström, E., 2015, Oncology, Kamprad Lab. 48 p.
Research output: Thesis › Doctoral Thesis (compilation)

Open Access
File

Cite this

@article{c4555b4baf864139be216fda223ebec1,

title = "Evaluation of immune cell markers in tumor tissue treated with radioimmunotherapy in an immunocompetent rat colon carcinoma model.",

abstract = "Immune cells within the tumor can act either to promote growth or rejection of tumor cells. The aim of the present study was to evaluate immune cell markers (number and localization) within the tumor before and during rejection due to radioimmunotherapy, to determine whether there is a change in markers related to rejection and/or tolerance of the tumor cells.",

author = "Erika Elgstr{\"o}m and Sophie Eriksson and Otto Ljungberg and P{\"a}r-Ola Bendahl and Ohlsson, {Tomas G} and Rune Nilsson and Jan Tennvall",

year = "2015",

doi = "10.1186/s13550-015-0126-y",

language = "English",

volume = "5",

journal = "EJNMMI Research",

issn = "2191-219X",

publisher = "BioMed Central (BMC)",

}

TY - JOUR

T1 - Evaluation of immune cell markers in tumor tissue treated with radioimmunotherapy in an immunocompetent rat colon carcinoma model.

AU - Elgström, Erika

AU - Eriksson, Sophie

AU - Ljungberg, Otto

AU - Bendahl, Pär-Ola

AU - Ohlsson, Tomas G

AU - Nilsson, Rune

AU - Tennvall, Jan

PY - 2015

Y1 - 2015

N2 - Immune cells within the tumor can act either to promote growth or rejection of tumor cells. The aim of the present study was to evaluate immune cell markers (number and localization) within the tumor before and during rejection due to radioimmunotherapy, to determine whether there is a change in markers related to rejection and/or tolerance of the tumor cells.

AB - Immune cells within the tumor can act either to promote growth or rejection of tumor cells. The aim of the present study was to evaluate immune cell markers (number and localization) within the tumor before and during rejection due to radioimmunotherapy, to determine whether there is a change in markers related to rejection and/or tolerance of the tumor cells.

U2 - 10.1186/s13550-015-0126-y

DO - 10.1186/s13550-015-0126-y

M3 - Article

C2 - 26374556

SN - 2191-219X

VL - 5

JO - EJNMMI Research

JF - EJNMMI Research

M1 - 47

ER -

Evaluation of immune cell markers in tumor tissue treated with radioimmunotherapy in an immunocompetent rat colon carcinoma model.

Abstract

Subject classification (UKÄ)

UN SDGs

Access to Document

Fingerprint

Research output

Radioimmunotherapy in an Immunocompetent Tumor Model utilizing a 177Lu-mAb

Cite this